Unlocking the Value of Data in Drug Discovery
Infographic Jul 31, 2018 | by Laura Elizabeth Mason, Science Writer for Technology Networks
As drug discovery approaches become increasingly automated there is great potential to accelerate the development of a drug from bench-to-bedside. The sheer volume of data generated in the process has sky-rocketed – it is vital you adopt the right tools to enable you to store, integrate and analyze drug discovery data as efficiently as possible.
Download this infographic to learn about:
- Some of the challenges associated with drug discovery data
- The factors that define ‘big data’
- Ways data analysis tools are helping accelerate drug discovery efforts
Over recent years, the number of newly approved drugs brought to market has continued to decrease. Many drugs fail due to the fact they do not show efficacy at specific stages of the drug development pipeline, typically Phase II or Phase III. Subsequently, the pharmaceutical industry is facing pressures to optimize the drug discovery phase of the drug development pipeline, to avoid late-stage failures, and streamline the process. One approach to doing this is by adopting automation.READ MORE